FDA Panel Rejects Drugs to Prevent Prostate Cancer

An FDA advisory committee has voted against approval of two drugs for the prevention of prostate cancer because of a link to increased risk of high-grade, aggressive forms of the disease.

Original post:

FDA Panel Rejects Drugs to Prevent Prostate Cancer

Posted by on December 2, 2010. Filed under Health, News. You can follow any responses to this entry through the RSS 2.0. You can leave a response or trackback to this entry